Aegerion Pharmaceuticals uses 8 technology products and services including Microsoft Word, Twitter Emoji (Twemoji), Chart.js, and more. Explore Aegerion Pharmaceuticals's tech stack below.
| Aegerion Pharmaceuticals Email Formats | Percentage |
| First.Last@aegerion.com | 47% |
| FLast@aegerion.com | 20% |
| FirstLast@aegerion.com | 6% |
| Last@aegerion.com | 5% |
| First-Last@aegerion.com | 3% |
| F_Last@aegerion.com | 3% |
| LastFirst@aegerion.com | 4% |
| FirstL@aegerion.com | 2% |
| LastFir@aegerion.com | 2% |
| FirLast@aegerion.com | 1% |
| First.MiddleLast@aegerion.com | 1% |
| First.Middle@aegerion.com | 2% |
| FMLast@aegerion.com | 1% |
| First_Last@aegerion.com | 1% |
| Last.First@aegerion.com | 1% |
| First-L@aegerion.com | 1% |
| First.Last@amrytpharma.com | 98% |
| First.Middle@amrytpharma.com | 2% |
Biotechnology ResearchDublin 4, Ireland201-500 Employees
Aegerion Pharmaceuticals was acquired by Amryt Pharma plc 24 September 2019. Amryt is a biopharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of patients with rare and orphan diseases. Amryt comprises a growing commercial business and a significant development pipeline. Please Follow us at https://www.linkedin.com/company/amryt-pharma-plc/
Company Overview
Media & News
Funding & FinancialsAegerion Pharmaceuticals has raised a total of $1.5M of funding over 5 rounds. Their latest funding round was raised on Oct 11, 2010 in the amount of $1.5M.
Aegerion Pharmaceuticals's revenue is in the range of $50M$100M
Funding & FinancialsAegerion Pharmaceuticals has raised a total of $1.5M of funding over 5 rounds. Their latest funding round was raised on Oct 11, 2010 in the amount of $1.5M.
Aegerion Pharmaceuticals's revenue is in the range of $50M$100M
1-888-653-2347 
support@leadiq.com